Brooklyn Roasting Company Recalls Cold Brew Over Botulism Risk

The Brooklyn Roasting Company has issued a recall for certain cold brew concentrate sold in New York and New Jersey due to the potential for botulism, a serious and potentially fatal illness. The recall, announced this month and reported by the U.S. Food and Drug Administration, specifically targets 2.5-gallon bags of pasteurized cold brew concentrate.

According to the FDA, the risk arises from the possibility of Clostridium botulinum toxin formation if the product is stored at room temperature. The affected products were distributed between April 1 and June 20, with best-by dates ranging from June 3 to September 30.

Botulism is a rare but severe condition caused by a toxin that attacks the nervous system. Symptoms typically appear 12 to 36 hours after exposure and can include difficulty swallowing, dry mouth, blurred vision, drooping eyelids, stomach upset, breathing problems, and paralysis. The FDA advises anyone experiencing these symptoms to seek immediate emergency medical attention.

As of the recall announcement, there have been no reported illnesses linked to the Brooklyn Roasting Company's cold brew products. The company distributes its products through its own cafés, other coffee shops, gourmet grocery stores, independent markets, and online sales. The specific markets where the recalled cold brew was distributed were not detailed.

The Brooklyn Roasting Company did not immediately respond to requests for comment.